.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Baxter
Julphar
Dow
Fish and Richardson
Boehringer Ingelheim
Medtronic
Federal Trade Commission
Farmers Insurance
Harvard Business School
Merck

Generated: September 23, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 203200

« Back to Dashboard
NDA 203200 describes IBUPROFEN AND PHENYLEPHRINE HYDROCHLORIDE, which is a drug marketed by Perrigo R And D and is included in one NDA. It is available from thirteen suppliers. Additional details are available on the IBUPROFEN AND PHENYLEPHRINE HYDROCHLORIDE profile page.

The generic ingredient in IBUPROFEN AND PHENYLEPHRINE HYDROCHLORIDE is ibuprofen; phenylephrine hydrochloride. There are sixty-four drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the ibuprofen; phenylephrine hydrochloride profile page.

Summary for NDA: 203200

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 203200

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
IBUPROFEN AND PHENYLEPHRINE HYDROCHLORIDE
ibuprofen; phenylephrine hydrochloride
TABLET;ORAL 203200 ANDA Walgreen Company 0363-0158 0363-0158-46 10 BLISTER PACK in 1 CARTON (0363-0158-46) > 1 TABLET, FILM COATED in 1 BLISTER PACK
IBUPROFEN AND PHENYLEPHRINE HYDROCHLORIDE
ibuprofen; phenylephrine hydrochloride
TABLET;ORAL 203200 ANDA Rugby Laboratories 0536-1044 0536-1044-19 10 BLISTER PACK in 1 CARTON (0536-1044-19) > 1 TABLET, FILM COATED in 1 BLISTER PACK

Summary for product number 001

Active Rx/OTC/Discontinued:OTCDosage:TABLET;ORALStrength200MG;10MG
Approval Date:Jul 3, 2014TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Healthtrust
Express Scripts
Daiichi Sankyo
McKesson
AstraZeneca
Citi
Moodys
Queensland Health
Deloitte
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot